Search results
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 1 day agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 18 hours ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 8 hours agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
Vision-Language Models for Feature Detection of Macular Diseases on Optical Coherence Tomography
Journal of the American Medical Association· 6 days agoThis cross-sectional study evaluates the performance of a vision-language model in performing ophthalmologic tasks related to interpretation of optical coherence tomography scans.
Research to Prevent Blindness Opens Applications for Vision Research Grants
Newswise· 3 days ago(RPB) is pleased to announce that it has opened a new round of grant funding for high-impact vision research. With a focus on scientific excellence, RPB funds research across all sight-threatening ...
Retinal hemorrhage: Causes, risk factors, and symptoms
Medical News Today· 7 days agoWhat is a retinal hemorrhage? Read on to learn more about bleeding in the eye, including different...
Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences
WKBN 27 Youngstown· 6 days agoAt the OIS Retina Innovation...
Can You Take Vitamin C and Iron Together?
Health via Yahoo News· 7 days agoIron is often sold in products that also contain vitamin C. Vitamin C can enhance iron absorption, but, as with all supplements, there are...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoWhile development potential and interest for this novel treatment approach is high for more rare inherited conditions such as retinitis pigmentosa and Stargardt's, Spherix's ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 hours agoGenerated $172.3 million in 1Q 2024 revenues, including $163.1 million in U.S. net product sales $137.5 million for SYFOVRE® (pegcetacoplan injection) $25.6 million for EMPAVELI® (pegcetacoplan) Anticipates CHMP opinion for pegcetacoplan in GA
